FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention discloses a stable vaccine composition containing at least one immunogen specified in an inactivated porcine circovirus type 2 (PCV-2), foot-and-mouth disease virus (FMDV) and bacteria; saponin, aluminium hydroxide, non-ionic surfactants with the final hydrophilic-lipophilic balance of the emulsion from approximately 9 to approximately 12.
EFFECT: invention maintains stability over a commercially effective period of time.
11 cl, 9 dwg, 16 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VACCINE COMPOSITION AND METHOD OF IMMUNE RESPONSE INDUCTION IN ANIMALS | 2004 |
|
RU2354399C2 |
| METHOD FOR PREPARING VACCINE COMPOSITION CONTAINING AT LEAST ONE ANTIGEN AND AT LEAST ONE ADJUVANT | 2008 |
|
RU2500421C2 |
| NOVEL COMPOSITIONS OF VACCINES | 2006 |
|
RU2422155C2 |
| FMDV VACCINES BASED ON A RECOMBINANT ADENOVIRAL VECTOR AND USE THEREOF | 2017 |
|
RU2725495C2 |
| MICROFLUIDISED OIL-IN-WATER EMULSIONS AND VACCINE COMPOSITIONS | 2005 |
|
RU2347586C2 |
| MUCROFLUIDIC OIL-IN-WATER EMULSION AND VACCINE COMPOSITIONS | 2004 |
|
RU2541809C2 |
| EMULSIONS OF “OIL-IN-WATER” TYPE, WHICH CONTAIN NUCLEIC ACIDS | 2012 |
|
RU2606846C2 |
| IMMUNOGENIC COMPOSITIONS OF Bordetella bronchiseptica | 2012 |
|
RU2554480C2 |
| KIT FOR PREPARING IMMUNOGENIC COMPOSITION FOR SEROGROUP B Neisseria meningitidis | 2008 |
|
RU2498815C2 |
| NEW VACCINE COMPOSITIONS COMPRISING IMMUNOSTIMULATORY OLIGONUCLEOTIDES | 2014 |
|
RU2627447C2 |
